Walleye Trading’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $56.1K | Sell |
2,400
-39,500
| -94% | -$715K | ﹤0.01% | 3654 |
|
|
2025
Q4 | $595K | Buy |
41,900
+25,800
| +160% | +$488K | ﹤0.01% | 2719 |
|
|
2025
Q3 | $399K | Buy |
16,100
+12,100
| +303% | +$270K | ﹤0.01% | 2897 |
|
|
2025
Q2 | $90.8K | Buy |
4,000
+3,900
| +3,900% | +$92.4K | ﹤0.01% | 3629 |
|
|
2025
Q1 | $3.03K | Buy |
+100
| New | +$3.81K | ﹤0.01% | 3918 |
|
|
2024
Q4 | – | Sell |
-5,700
| Closed | -$361K | – | 4190 |
|
|
2024
Q3 | $361K | Buy |
+5,700
| New | +$412K | ﹤0.01% | 2722 |
|
|
2024
Q1 | – | Sell |
-64,300
| Closed | -$5M | – | 4676 |
|
|
2023
Q4 | $5M | Buy |
64,300
+64,200
| +64,200% | +$4.75M | 0.01% | 1243 |
|
|
2023
Q3 | $7.03K | Sell |
100
-100
| -50% | -$7.47K | ﹤0.01% | 4576 |
|
|
2023
Q2 | $15.9K | Sell |
200
-200
| -50% | -$14.5K | ﹤0.01% | 4173 |
|
|
2023
Q1 | $28.9K | Buy |
+400
| New | +$31.2K | ﹤0.01% | 4187 |
|
|
2021
Q1 | – | Sell |
-2,700
| Closed | -$136K | – | 4730 |
|
|
2020
Q4 | $136K | Buy |
2,700
+1,100
| +69% | +$43.8K | ﹤0.01% | 3764 |
|
|
2020
Q3 | $47K | Buy |
1,600
+1,500
| +1,500% | +$43.5K | ﹤0.01% | 3651 |
|
|
2020
Q2 | $3K | Sell |
100
-4,300
| -98% | -$107K | ﹤0.01% | 4142 |
|
|
2020
Q1 | $81K | Buy |
4,400
+3,800
| +633% | +$109K | ﹤0.01% | 3230 |
|
|
2019
Q4 | $20K | Buy |
+600
| New | +$18.8K | ﹤0.01% | 3990 |
|
|
2019
Q2 | – | Sell |
-2,600
| Closed | -$76K | – | 3964 |
|
|
2019
Q1 | $76K | Sell |
2,600
-100
| -4% | -$2.83K | ﹤0.01% | 3573 |
|
|
2018
Q4 | $69K | Buy |
2,700
+2,200
| +440% | +$76.1K | ﹤0.01% | 4032 |
|
|
2018
Q3 | $18K | Sell |
500
-10,000
| -95% | -$398K | ﹤0.01% | 4862 |
|
|
2018
Q2 | $430K | Buy |
+10,500
| New | +$423K | ﹤0.01% | 2976 |
|
|
2018
Q1 | – | Sell |
-16,100
| Closed | -$525 | – | 4429 |
|
|
2017
Q4 | $525 | Buy |
16,100
+15,800
| +5,267% | +$547K | ﹤0.01% | 2555 |
|
|
2017
Q3 | $15 | Buy |
+300
| New | +$14.6K | ﹤0.01% | 3943 |
|
|
2017
Q2 | – | Sell |
-7,500
| Closed | -$327 | – | 4442 |
|
|
2017
Q1 | $327 | Buy |
7,500
+6,800
| +971% | +$276K | ﹤0.01% | 2590 |
|
|
2016
Q4 | $23K | Sell |
700
-800
| -53% | -$31K | ﹤0.01% | 4030 |
|
|
2016
Q3 | $75K | Buy |
1,500
+700
| +88% | +$36.5K | ﹤0.01% | 3493 |
|
|
2016
Q2 | $45K | Sell |
800
-8,300
| -91% | -$485K | ﹤0.01% | 4038 |
|
|
2016
Q1 | $502K | Buy |
+9,100
| New | +$519K | ﹤0.01% | 1972 |
|
Other funds holding ACHC
KCM
VPM
DM
DCM
ABI
VCM
Walleye Trading's ACHC Position: Q1 2026 in Review
Walleye Trading sold out of Acadia Healthcare (ACHC) in Q1 2026, closing a stake of 26,309 shares — an estimated $476K sold.
Walleye Trading first reported a position in ACHC in Q2 2015 and held it in 17 quarters. The position peaked at $4.93M in Q1 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.
- Walleye Trading reported no remaining Acadia Healthcare position as of Q1 2026 after selling out during the quarter.
- Walleye Trading sold 26,309 Acadia Healthcare shares in Q1 2026, an estimated $476K.
- Walleye Trading first reported a position in Acadia Healthcare in Q2 2015 and held it in 17 quarters.
- Walleye Trading's Acadia Healthcare position peaked at $4.93M in Q1 2025.
- 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.
Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.